Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;49(1):57-67.
doi: 10.1016/j.ecl.2019.10.001. Epub 2019 Nov 18.

Benefits and Challenges of Diabetes Technology Use in Older Adults

Elena Toschi  1 , Medha N Munshi  2
Affiliations
Review

Benefits and Challenges of Diabetes Technology Use in Older Adults

Elena Toschi et al. Endocrinol Metab Clin North Am. 2020 Mar.

Abstract

With successful aging of adults with type 1 diabetes, there is an increased opportunity to use technology for diabetes management. Technology can ease the burden of self-care and provide a sense of security. However, age-related cognitive and physical decline can make technology use difficult. Guidelines using technology in the aging population are urgently needed, along with educational material for the clinicians and caregivers. In this article, we review the evidence supporting the use of diabetes-related technologies in the older population and discuss recommendations based on current data and the authors' clinical knowledge and experience.

Trial registration: ClinicalTrials.gov NCT03078491.

Keywords: Continuous glucose monitoring; Older adults; Subcutaneous continuous insulin infusion; Technology; Type 1 diabetes mellitus; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Disclosure Dr M.N. Munshi is a consultant for Lilly and Sanofi. No disclosure for Dr E. Toschi.

Figures

Figure 1
Figure 1
Steps to consider in the Use of Diabetes Technology and Goals of Care in Older Adults to Improve Diabetes and Quality of Life Outcomes.
See this image and copyright information in PMC

References

    1. American Diabetes A. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42:S71–S80. - PubMed
    1. Jeitler K, Horvath K, Berghold A, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008;51:941–51. - PubMed
    1. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765–74. - PubMed
    1. Karges B, Schwandt A, Heidtmann B, et al. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA 2017;318:1358–66. - PMC - PubMed
    1. Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464–76. - PubMed

Publication types

MeSH terms

Associated data